In 2013, Congress passed the Drug Supply Chain Security Act, often called the “track and trace” law, which is designed protect consumers against counterfeit drugs. In November 2020, new requirements for pharmacists took effect.
To learn more about what pharmacists need to know, we spoke with Ilisa Bernstein, senior vice president for government affairs and pharmacy practice at APhA; and Leigh Verbois, director of the Office of Drug Security, Integrity and Response for the FDA’s Center for Drug Evaluation and Research.
Where's the Patient's Voice in Evidence-based Treatment & Research? | Pharmacist and Physician Opioid Collaborative